SCHEMBL5522528

SCHEMBL5522528

COC(=O)c1cc(-c2ccc(C)cn2)n(-c2ccc(Cl)nn2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.40
SMN1; SMN2 Q16637 5/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
RAB9A P51151 1/20 0.35
PTGS2 P35354 1/20 0.33
PPP1CA P62136 1/20 0.33
FAAH O00519 1/20 0.33
MGLL Q99685 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RXRA P19793 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
APP P05067 1/20 0.32
MAPT P10636 1/20 0.32
RPA1 P27694 1/20 0.32
MMP2 P08253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933068 0.90 CA9 (0.42) ALOX5SMN1; SMN2KMT2ARAB9AFAAH
SCHEMBL27648500 0.88 PPP1CA (0.45) ALOX5SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL5527972 0.88 ALOX5 (0.37) ALOX5SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL5269426 0.87 SMN1; SMN2 (0.38) ALOX5SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL5266014 0.87 EGLN2 (0.39) ALOX5SMN1; SMN2MEN1KMT2ARPA1
SCHEMBL2917351 0.84 SLC16A3 (0.40) SMN1; SMN2MEN1KMT2ARAB9AFAAH
SCHEMBL5266028 0.83 RAB9A (0.39) ALOX5SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL5524845 0.82 MDM2 (0.43) ALOX5SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL5268843 0.82 SMN1; SMN2 (0.38) ALOX5SMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL2918705 0.81 CHRNA7 (0.45) ALOX5SMN1; SMN2KMT2ARAB9AFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070219210-A1 Amidopyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-09-20 US disclosed
CN-1902191-A Amidopyrazole derivative DAIICHI SEIYAKU CO (JP) 2007-01-24 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070219210-A1 Amidopyrazole Derivative PTGER1, PTGS1, PTGER2 ALOX5 36/4885SMN1; SMN2 4048/4885MEN1 2899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.